P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Kevin H. Lin; Justine C. Rutter; Abigail Xie; Shane T. Killarney; Camille Vaganay; Chaima Benaksas; Frank Ling; Gaetano Sodaro; Paul-Arthur Meslin; Christopher F. Bassil; Nina Fenouille; Jacob Hoj; Rachel Washart; Hazel X. Ang; Christian Cerda-Smith; Paul Chaintreuil; Arnaud Jacquel; Patrick Auberger; Antoine Forget; Raphael Itzykson; Min Lu; Jiaxing Lin; Mariaelena Pierobon; Zhecheng Sheng; Xingh

Journal title: Nat Cancer

Journal number: 1

Journal publisher: Nature Publishing Group

Published year: 2022

DOI identifier: 10.1038/s43018-022-00394-x

ISSN: 2662-1347